ketoconazole and (3,4-dihydroxyphenylamino)-2-imidazoline

ketoconazole has been researched along with (3,4-dihydroxyphenylamino)-2-imidazoline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishihara, Y; Shiba, D; Shimamoto, N1

Other Studies

1 other study(ies) available for ketoconazole and (3,4-dihydroxyphenylamino)-2-imidazoline

ArticleYear
Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition.
    Toxicology and applied pharmacology, 2006, Jul-15, Volume: 214, Issue:2

    Topics: Animals; Antioxidants; Benzoquinones; Catecholamines; Cell Survival; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glutathione Disulfide; Hepatocytes; Imidazolines; Iron Chelating Agents; Ketoconazole; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Metyrapone; Molecular Structure; NADP; Naphthoquinones; Oxidative Stress; Proadifen; Rats; Rats, Wistar; Superoxides; Thiobarbituric Acid Reactive Substances

2006